Pre-conditioning by Balloon-inflation on Myocardial Injury (BaMI)
Primary Purpose
Myocardial Ischemia
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Pre-conditioning
Sponsored by
About this trial
This is an interventional treatment trial for Myocardial Ischemia
Eligibility Criteria
Inclusion Criteria:
- Age ≥18 years.
Indication for complex PCI, defined as:
- PCI of a chronic total occlusion
- Two-stent PCI of a bifurcation lesion.
- PCI of severely calcified lesion
- Preprocedural biomarker Troponin-I within normal range
- Left ventricular ejection fraction >50%
- Written informed consent obtained
Exclusion Criteria:
- Previous randomization in the study
- Decompensated heart failure requiring inotropic /adrenergic support, invasive or non-invasive ventilation or intra-aortic balloon pump/ventricular assist device therapy less than 48 hours prior to randomization
- Recent PCI (<3 months)
- Known previous myocardial infarction in the target vessel or regional wall motion abnormalities within the myocardium subtended by the target vessel(s)
- Any contraindication for Cardiac magnetic resonance imaging
- Pregnancy
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Other
No Intervention
Arm Label
Pre-conditioning
Controll
Arm Description
Pre-conditioning by three consecutive 60 seconds balloon inflations, spaced 120 seconds apart followed by 10 minutes rest prior to PCI
No pre-conditioning, standard care
Outcomes
Primary Outcome Measures
Cardiac troponin-I
Area-under the curve of cardiac troponin-I
Infarct size
Procedural infarct size as assessed by cardiac magnetic resonance imaging
Infarct size
Procedural infarct size as assessed by cardiac magnetic resonance imaging
Secondary Outcome Measures
Full Information
NCT ID
NCT05149846
First Posted
November 11, 2021
Last Updated
April 27, 2022
Sponsor
Vastra Gotaland Region
Collaborators
Sahlgrenska University Hospital, Sweden
1. Study Identification
Unique Protocol Identification Number
NCT05149846
Brief Title
Pre-conditioning by Balloon-inflation on Myocardial Injury
Acronym
BaMI
Official Title
Effect of Pre-conditioning by Balloon-inflation on Myocardial Injury During Complex Percutaneous Coronary Intervention - a Clinical Trial
Study Type
Interventional
2. Study Status
Record Verification Date
November 2021
Overall Recruitment Status
Not yet recruiting
Study Start Date
January 1, 2023 (Anticipated)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Vastra Gotaland Region
Collaborators
Sahlgrenska University Hospital, Sweden
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Study objectives:
To test pre-conditioning by three consecutive 60 seconds balloon inflations, spaced 120 seconds apart, followed by 10 minutes rest prior to PCI reduces the risk of myocardial injury.
Study design:
Single-center, open-label, randomized controlled trial
Study population:
Patients with indication for complex PCI. Patients will be randomized prior to PCI to pre-conditioning by intracoronary balloon inflation in the target vessel proximal to the target lesion(s) versus no pre-conditioning followed by a 10-minute waiting period prior to PCI. PCI will then be performed as per standard of care. Cardiac biomarkers will be drawn at baseline and 6, 24 and 48 hours after PCI. Cardiac magnetic resonance imaging will be performed at 48 hours and 6 months post PCI.
Detailed Description
The primary objective of this study is to test pre-conditioning by three consecutive 60 seconds balloon inflations, spaced 120 seconds apart followed by 10 minutes rest prior to percutaneous coronary intervention (PCI) reduces the risk of myocardial injury.
Except for the extended duration of balloon inflations, no study-specific therapy will be administered to the patients. All patients will receive treatment according to current guidelines. A follow-up visit will be performed at approximately 6, 24, 48 hours and at 6 months.
The population studied are patients with indication for complex PCI. Patients will be randomized, after providing written informed consent, prior to PCI to pre-conditioning by three consecutive intracoronary balloon inflation in the target vessel proximal to the target lesion(s) versus no pre-conditioning followed by a 10-minute waiting period prior to PCI, PCI will then be performed as per standard of care. Cardiac biomarkers will be drawn at baseline and 6 hours, 24 hours and 48 hours after PCI. Cardiac magnetic resonance imaging will be performed at 48 hours and 6 months post PCI.
Three consecutive balloon occlusions performed for approximate 60 seconds and spaced approximate 120 seconds apart, followed by a 10-minute waiting period prior to PCI.
Cardiac Magnetic Resonance imaging (CMR) will be used to assess size of myocardial infarction at 48±6 hours and 6 months±30 days post PCI. CMR examination includes administration of contrast and one additional blood test (hematocrit, necessary to assess extracellular volume).
Echocardiography can be used before randomization as per standard of care before PCI. Echocardiography will be used to assess wall motion score index, left ventricular ejection fraction at 24 hours and serial examinations can be performed at the discretion of the PI 12-lead Electrocardiogram (ECG) will be used to assess at baseline, during intervention, at 48 hours and serial examinations can be performed at the discretion of the PI.
Apart from the routine laboratory tests, blood samples (troponin-I, troponin-T, creatine kinase MB fraction [CKMB]) will be collected at baseline, 6±1 hour, 24±6 hours 48±6 hours after PCI. After collection blood samples will be analyzed at hospitals clinical laboratory and destructed directly after analyses.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Myocardial Ischemia
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
Randomized controlled trial
Masking
None (Open Label)
Allocation
Randomized
Enrollment
250 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Pre-conditioning
Arm Type
Other
Arm Description
Pre-conditioning by three consecutive 60 seconds balloon inflations, spaced 120 seconds apart followed by 10 minutes rest prior to PCI
Arm Title
Controll
Arm Type
No Intervention
Arm Description
No pre-conditioning, standard care
Intervention Type
Procedure
Intervention Name(s)
Pre-conditioning
Intervention Description
Pre-conditioning by three consecutive 60 seconds balloon inflations, spaced 120 seconds apart followed by 10 minutes rest prior to PCI
Primary Outcome Measure Information:
Title
Cardiac troponin-I
Description
Area-under the curve of cardiac troponin-I
Time Frame
within 48 hours
Title
Infarct size
Description
Procedural infarct size as assessed by cardiac magnetic resonance imaging
Time Frame
48 hours
Title
Infarct size
Description
Procedural infarct size as assessed by cardiac magnetic resonance imaging
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age ≥18 years.
Indication for complex PCI, defined as:
PCI of a chronic total occlusion
Two-stent PCI of a bifurcation lesion.
PCI of severely calcified lesion
Preprocedural biomarker Troponin-I within normal range
Left ventricular ejection fraction >50%
Written informed consent obtained
Exclusion Criteria:
Previous randomization in the study
Decompensated heart failure requiring inotropic /adrenergic support, invasive or non-invasive ventilation or intra-aortic balloon pump/ventricular assist device therapy less than 48 hours prior to randomization
Recent PCI (<3 months)
Known previous myocardial infarction in the target vessel or regional wall motion abnormalities within the myocardium subtended by the target vessel(s)
Any contraindication for Cardiac magnetic resonance imaging
Pregnancy
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Björn Redfors, MD, PhD
Phone
+46 31 3427543
Email
Bjorn.redfors@wlab.gu.se
First Name & Middle Initial & Last Name or Official Title & Degree
Margareta Scharin Täng, PhD
Phone
+46 700207968
Email
margareta.scharin.tang@vgregion.se
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Björn Redfors, MD, PhD
Organizational Affiliation
Vastra Gotaland Region
Official's Role
Principal Investigator
12. IPD Sharing Statement
Learn more about this trial
Pre-conditioning by Balloon-inflation on Myocardial Injury
We'll reach out to this number within 24 hrs